Molecular mechanism of bystander effects and related abscopal/ cohort effects in cancer therapy

Rong Wang, Tingyang Zhou, Wei Liu, Li Zuo

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Cancer cells subjected to ionizing radiation may release signals which can influence nearby non-irradiated cells, termed bystander effects. The transmission of bystander effects among cancer cells involves the activation of inflammatory cytokines, death ligands, and reactive oxygen/nitrogen species. In addition to bystander effects, two other forms of non-target effects (NTEs) have been identified in radiotherapy, as one is called cohort effects and the other is called abscopal effects. Cohort effects represent the phenomenon where irradiated cells can produce signals that reduce the survival of neighboring cells within an irradiated volume. The effects suggest the importance of cellular communication under irradiation with non-uniform dose distribution. In contrast, abscopal effects describe the NTEs that typically occur in non-irradiated cells distant from an irradiated target. These effects can be mediated primarily by immune cells such as T cells. Clinical trials have shown that application of radiation along with immunotherapy may enhance abscopal effects and improve therapeutic efficacy on non-target lesions outside an irradiated field. According to NTEs, cell viability is reduced not only by direct irradiation effects, but also due to signals emitted from nearby irradiated cells. A clinical consideration of NTEs could have a revolutionary impact on current radiotherapy via the establishment of more efficient and less toxic radiobiological models for treatment planning compared to conventional models. Thus, we will review the most updated findings about these effects and outline their mechanisms and potential applications in cancer treatment with a special focus on the brain, lung, and breast cancers.

Original languageEnglish (US)
Pages (from-to)18637-18647
Number of pages11
JournalOncotarget
Volume9
Issue number26
DOIs
StatePublished - Apr 1 2018

Fingerprint

Bystander Effect
Cohort Effect
Neoplasms
Therapeutics
Cell Survival
Radiotherapy
Reactive Nitrogen Species
Poisons
Therapeutic Uses
Ionizing Radiation
Brain Neoplasms
Immunotherapy
Reactive Oxygen Species
Lung Neoplasms
Clinical Trials
Radiation
Breast Neoplasms
Cytokines
Ligands
T-Lymphocytes

Keywords

  • Non-targeted effects
  • Non-uniform irradiation
  • P53
  • Radiation therapy
  • Reactive oxygen species

ASJC Scopus subject areas

  • Oncology

Cite this

Molecular mechanism of bystander effects and related abscopal/ cohort effects in cancer therapy. / Wang, Rong; Zhou, Tingyang; Liu, Wei; Zuo, Li.

In: Oncotarget, Vol. 9, No. 26, 01.04.2018, p. 18637-18647.

Research output: Contribution to journalReview article

Wang, Rong ; Zhou, Tingyang ; Liu, Wei ; Zuo, Li. / Molecular mechanism of bystander effects and related abscopal/ cohort effects in cancer therapy. In: Oncotarget. 2018 ; Vol. 9, No. 26. pp. 18637-18647.
@article{6d7bef785c8b4ce984b650d52ec00815,
title = "Molecular mechanism of bystander effects and related abscopal/ cohort effects in cancer therapy",
abstract = "Cancer cells subjected to ionizing radiation may release signals which can influence nearby non-irradiated cells, termed bystander effects. The transmission of bystander effects among cancer cells involves the activation of inflammatory cytokines, death ligands, and reactive oxygen/nitrogen species. In addition to bystander effects, two other forms of non-target effects (NTEs) have been identified in radiotherapy, as one is called cohort effects and the other is called abscopal effects. Cohort effects represent the phenomenon where irradiated cells can produce signals that reduce the survival of neighboring cells within an irradiated volume. The effects suggest the importance of cellular communication under irradiation with non-uniform dose distribution. In contrast, abscopal effects describe the NTEs that typically occur in non-irradiated cells distant from an irradiated target. These effects can be mediated primarily by immune cells such as T cells. Clinical trials have shown that application of radiation along with immunotherapy may enhance abscopal effects and improve therapeutic efficacy on non-target lesions outside an irradiated field. According to NTEs, cell viability is reduced not only by direct irradiation effects, but also due to signals emitted from nearby irradiated cells. A clinical consideration of NTEs could have a revolutionary impact on current radiotherapy via the establishment of more efficient and less toxic radiobiological models for treatment planning compared to conventional models. Thus, we will review the most updated findings about these effects and outline their mechanisms and potential applications in cancer treatment with a special focus on the brain, lung, and breast cancers.",
keywords = "Non-targeted effects, Non-uniform irradiation, P53, Radiation therapy, Reactive oxygen species",
author = "Rong Wang and Tingyang Zhou and Wei Liu and Li Zuo",
year = "2018",
month = "4",
day = "1",
doi = "10.18632/oncotarget.24746",
language = "English (US)",
volume = "9",
pages = "18637--18647",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "26",

}

TY - JOUR

T1 - Molecular mechanism of bystander effects and related abscopal/ cohort effects in cancer therapy

AU - Wang, Rong

AU - Zhou, Tingyang

AU - Liu, Wei

AU - Zuo, Li

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Cancer cells subjected to ionizing radiation may release signals which can influence nearby non-irradiated cells, termed bystander effects. The transmission of bystander effects among cancer cells involves the activation of inflammatory cytokines, death ligands, and reactive oxygen/nitrogen species. In addition to bystander effects, two other forms of non-target effects (NTEs) have been identified in radiotherapy, as one is called cohort effects and the other is called abscopal effects. Cohort effects represent the phenomenon where irradiated cells can produce signals that reduce the survival of neighboring cells within an irradiated volume. The effects suggest the importance of cellular communication under irradiation with non-uniform dose distribution. In contrast, abscopal effects describe the NTEs that typically occur in non-irradiated cells distant from an irradiated target. These effects can be mediated primarily by immune cells such as T cells. Clinical trials have shown that application of radiation along with immunotherapy may enhance abscopal effects and improve therapeutic efficacy on non-target lesions outside an irradiated field. According to NTEs, cell viability is reduced not only by direct irradiation effects, but also due to signals emitted from nearby irradiated cells. A clinical consideration of NTEs could have a revolutionary impact on current radiotherapy via the establishment of more efficient and less toxic radiobiological models for treatment planning compared to conventional models. Thus, we will review the most updated findings about these effects and outline their mechanisms and potential applications in cancer treatment with a special focus on the brain, lung, and breast cancers.

AB - Cancer cells subjected to ionizing radiation may release signals which can influence nearby non-irradiated cells, termed bystander effects. The transmission of bystander effects among cancer cells involves the activation of inflammatory cytokines, death ligands, and reactive oxygen/nitrogen species. In addition to bystander effects, two other forms of non-target effects (NTEs) have been identified in radiotherapy, as one is called cohort effects and the other is called abscopal effects. Cohort effects represent the phenomenon where irradiated cells can produce signals that reduce the survival of neighboring cells within an irradiated volume. The effects suggest the importance of cellular communication under irradiation with non-uniform dose distribution. In contrast, abscopal effects describe the NTEs that typically occur in non-irradiated cells distant from an irradiated target. These effects can be mediated primarily by immune cells such as T cells. Clinical trials have shown that application of radiation along with immunotherapy may enhance abscopal effects and improve therapeutic efficacy on non-target lesions outside an irradiated field. According to NTEs, cell viability is reduced not only by direct irradiation effects, but also due to signals emitted from nearby irradiated cells. A clinical consideration of NTEs could have a revolutionary impact on current radiotherapy via the establishment of more efficient and less toxic radiobiological models for treatment planning compared to conventional models. Thus, we will review the most updated findings about these effects and outline their mechanisms and potential applications in cancer treatment with a special focus on the brain, lung, and breast cancers.

KW - Non-targeted effects

KW - Non-uniform irradiation

KW - P53

KW - Radiation therapy

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=85044998854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044998854&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.24746

DO - 10.18632/oncotarget.24746

M3 - Review article

AN - SCOPUS:85044998854

VL - 9

SP - 18637

EP - 18647

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 26

ER -